دورية أكاديمية
أعرض في EDS

Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review.

التفاصيل البيبلوغرافية
العنوان: Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review.
المؤلفون: Serag H; Department of International Medicine, School of Medicine, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA., Clark I; HIV/STD Prevention & Care Unit, Texas Department of State Health Services, Austin, TX 78714, USA., Naig C; MPH Program, School of Public and Population Health, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA., Lakey D; Administration Division, University of Texas System, Austin, TX 78701, USA., Tiruneh YM; Department of Preventive Medicine and Population Health, School of Medicine, University of Texas Tyler, Tyler, TX 75799, USA.; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
المصدر: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Dec 27; Vol. 20 (1). Date of Electronic Publication: 2022 Dec 27.
نوع المنشور: Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI, c2004-
مواضيع طبية MeSH: Mass Screening*/methods , HIV Infections*/diagnosis , HIV Infections*/prevention & control, Aged ; United States ; Humans ; Medicare ; Delivery of Health Care ; Health Facilities
مستخلص: The Centers for Disease Control and Prevention recommends everyone between 13-64 years be tested for HIV at least once as a routine procedure. Routine HIV screening is reimbursable by Medicare, Medicaid, expanded Medicaid, and most commercial insurance plans. Yet, scaling-up HIV routine screening remains a challenge. We conducted a scoping review for studies on financial benefits and barriers associated with HIV screening in clinical settings in the U.S. to inform an evidence-based strategy to scale-up routine HIV screening. We searched Ovid MEDLINE ® , Cochrane, and Scopus for studies published between 2006-2020 in English. The search identified 383 Citations; we screened 220 and excluded 163 (outside the time limit, irrelevant, or outside the U.S.). Of the 220 screened articles, we included 35 and disqualified 155 (did not meet the eligibility criteria). We organized eligible articles under two themes: financial benefits/barriers of routine HIV screening in healthcare settings (9 articles); and Cost-effectiveness of routine screening in healthcare settings (26 articles). The review concluded drawing recommendations in three areas: (1) Finance: Incentivize healthcare providers/systems for implementing HIV routine screening and/or separate its reimbursement from bundle payments; (2) Personnel: Encourage nurse-initiated HIV screening programs in primary care settings and educate providers on CDC recommendations; and (3) Approach: Use opt-out approach.
Competing Interests: The authors declare no conflict of interest. Authors must identify and declare any personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. Isabel Clark, who contributed to the reviewing of the manuscript, has been working for the funder, the Department of State Health Services at the time of the manuscript development.
References: AIDS Behav. 2020 Feb;24(2):379-386. (PMID: 30953306)
AIDS. 2013 Mar 13;27(5):795-801. (PMID: 23169333)
J Emerg Med. 2012 Jun;42(6):719-26. (PMID: 21277144)
PLoS One. 2012;7(9):e45176. (PMID: 23028828)
J Clin Virol. 2011 Dec;52 Suppl 1:S29-33. (PMID: 22078147)
Am J Public Health. 2007 Dec;97(12):2173-8. (PMID: 17971545)
J Gen Intern Med. 2008 Jun;23(6):800-7. (PMID: 18421508)
J Adolesc Health. 2018 Jan;62(1):22-28. (PMID: 29273141)
AIDS. 2011 Sep 10;25(14):1779-87. (PMID: 21716076)
J Gen Intern Med. 2010 Jun;25(6):556-63. (PMID: 20204538)
PLoS One. 2011;6(11):e27625. (PMID: 22110698)
JAMA. 2010 Jul 21;304(3):284-92. (PMID: 20639562)
Ann Intern Med. 2006 Dec 5;145(11):I30. (PMID: 17146061)
AIDS Behav. 2018 Nov;22(11):3726-3733. (PMID: 29079947)
Am J Public Health. 2007 Oct;97(10):1762-74. (PMID: 17761565)
Clin Infect Dis. 2016 Jan 15;62(2):220-229. (PMID: 26362321)
Acad Emerg Med. 2012 Mar;19(3):287-93. (PMID: 22435861)
PLoS Med. 2010 Sep 28;7(9):e1000342. (PMID: 20927354)
JAMA. 2008 Aug 27;300(8):945-51. (PMID: 18728268)
J Clin Nurs. 2017 Dec;26(23-24):3832-3842. (PMID: 28252818)
N Engl J Med. 2016 Sep 1;375(9):830-9. (PMID: 27424812)
Ann Intern Med. 2010 Dec 21;153(12):778-89. (PMID: 21173412)
J Infect. 2016 Nov;73(5):476-484. (PMID: 27521468)
Clin Infect Dis. 2016 Feb 15;62(4):501-511. (PMID: 26508512)
Am J Public Health. 2018 Nov;108(S4):e1-e9. (PMID: 30383433)
PLoS One. 2015 Jun 08;10(6):e0128408. (PMID: 26053140)
BMJ. 2016 Jan 19;532:h6895. (PMID: 26786744)
Drug Alcohol Depend. 2013 Feb 1;128(1-2):90-7. (PMID: 22971593)
Health Care Manag Sci. 2006 May;9(2):143-9. (PMID: 16895309)
J Int AIDS Soc. 2020 Jan;23(1):e25445. (PMID: 31960580)
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):183-192. (PMID: 29135654)
Ann Intern Med. 2006 Dec 5;145(11):797-806. (PMID: 17146064)
Public Health Rep. 2018 Jan/Feb;133(1):3-21. (PMID: 29182894)
AIDS Patient Care STDS. 2013 Sep;27(9):511-7. (PMID: 23991689)
BMC Public Health. 2015 Sep 14;15:888. (PMID: 26369954)
Med Decis Making. 2012 May-Jun;32(3):459-69. (PMID: 22247422)
JAMA. 2019 Jun 18;321(23):2326-2336. (PMID: 31184701)
Acad Emerg Med. 2009 Aug;16(8):800-8. (PMID: 19673717)
Acad Emerg Med. 2011 Jul;18(7):745-53. (PMID: 21762236)
Clin Infect Dis. 2021 Oct 5;73(7):e1927-e1935. (PMID: 32730625)
Public Health Rep. 2016 Jan-Feb;131 Suppl 1:71-81. (PMID: 26862232)
Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S79-84. (PMID: 21684414)
Sex Transm Dis. 2014 Sep;41(9):545-50. (PMID: 25118967)
Int J Health Plann Manage. 2018 Jan;33(1):31-50. (PMID: 28556453)
AIDS Res Treat. 2012;2012:904916. (PMID: 22400107)
AIDS Care. 2017 Aug;29(8):1014-1018. (PMID: 28114789)
Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S104-13. (PMID: 21684388)
J Correct Health Care. 2018 Jul;24(3):309-319. (PMID: 29976088)
AIDS Behav. 2017 Mar;21(3):619-625. (PMID: 27624729)
Ann Intern Med. 2008 Jun 17;148(12):889-903. (PMID: 18559840)
HIV Med. 2012 Aug;13(7):416-26. (PMID: 22413900)
Pediatr Emerg Care. 2015 Sep;31(9):621-6. (PMID: 25834965)
Orthop Traumatol Surg Res. 2016 Jun;102(4):513-6. (PMID: 27062330)
J Neurosurg. 2018 Sep 14;131(3):941-948. (PMID: 30215562)
PLoS One. 2011;6(5):e19936. (PMID: 21625489)
J Int Assoc Provid AIDS Care. 2015 Mar-Apr;14(2):127-35. (PMID: 24643412)
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S8-15. (PMID: 25867782)
PLoS One. 2018 Jul 6;13(7):e0199833. (PMID: 29979742)
Curr HIV/AIDS Rep. 2016 Feb;13(1):64-75. (PMID: 26830283)
Value Health. 2012 Dec;15(8):1022-8. (PMID: 23244803)
Spec Care Dentist. 2019 Mar;39(2):188-200. (PMID: 30719739)
Health Psychol. 2009 Nov;28(6):675-81. (PMID: 19916635)
Public Health Rep. 2019 Sep/Oct;134(5):484-492. (PMID: 31365316)
Infect Dis Obstet Gynecol. 2018 Mar 14;2018:6024698. (PMID: 29731602)
معلومات مُعتمدة: HHS000387800001 Texas Department of State Health Services (DSHS)
فهرسة مساهمة: Keywords: HIV; HIV prevention; financial benefits; opt-out approach; routine screening
تواريخ الأحداث: Date Created: 20230108 Date Completed: 20230110 Latest Revision: 20230307
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9819288
DOI: 10.3390/ijerph20010457
PMID: 36612775
قاعدة البيانات: MEDLINE
الوصف
تدمد:1660-4601
DOI:10.3390/ijerph20010457